To include your compound in the COVID-19 Resource Center, submit it here.

Biopure updates financing plans

BPUR proposed to sell 25 million shares in a follow-on underwritten by Dawson James Securities. If sold

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE